Healthcare Stocks Dominate This Week's IPO Calendar

The IPO calendar is slower this week than it has been for some time, but there are still four companies hitting the market for investors to choose from.

Last week's 16 IPOs was the highest total for any week since 2006. According to investment research firm Renaissance Capital, there have been 91 IPOs priced in 2014, up 107% from this time last year. In fact, 2014 is on pace for more IPOs than any year since the "dot-com" Era of 1999 through 2001.

And among this year's IPOs, the healthcare industry has been the busiest industry, with 37 healthcare companies going public. That trend continued this week as three of the four companies going public operate in the healthcare industry.

Here's what investors need to know about each of this week's four initial public offerings…

IPO Calendar: Companies Hitting the Market This Week

Quotient Ltd. (Nasdaq: QTNT) is a commercial-stage diagnostics company that develops innovative tests for blood grouping and serological diseases screening. The company is planning to hit the Nasdaq on Tuesday, April 22. Through its IPO, QTNT is expecting to raise $50 million by offering 5 million shares at a range of $9 to $11, which would give the company a valuation of $149 million. In the last 12 months, QTNT has reported revenue of $19 million. The company is based in the United Kingdom.

SCYNEXIS (Nasdaq: SCYX) is a pharmaceutical company that develops treatments for life-threatening fungal infections. SCYX had initially planned its IPO for the week of April 7, but had pushed the date back until this week. The company plans to raise $55 million in its IPO by selling 7.3 million shares at a range of $7 to $8 per share. At the midpoint of that range, SCYX would have a valuation of $143 million. SCYX reported $17 million in sales in the past year. The company was founded in 1999.

While QTNT and SCYX are the two biggest IPOs this week, there are two other companies making their debuts…